Our engagements cluster around four sectors within pharma and healthcare manufacturing and commercialization.
Synthetic, biologic, HPAPI and sterile API feasibility and diligence work, plus competitive intelligence on manufacturers and pricing.
Formulation-stage feasibility and competitive tracking, including generic launch readiness ahead of patent expiries.
Distribution and channel-level diligence and intelligence, including trade vs. institutional positioning.
Diagnostics-sector feasibility and market studies alongside our core pharma work.